Amphastar Pharmaceuticals Inc. (NASDAQ: AMPH) stock closed at 34.28 per share at the end of the most recent trading day (a 7.87% change compared to the prior day closing price) with a volume of 368.07K shares and market capitalization of 1.67B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 2027 people. Amphastar Pharmaceuticals Inc. CEO is Jack Yongfeng Zhang.

The one-year performance of Amphastar Pharmaceuticals Inc. stock is 51.91%, while year-to-date (YTD) performance is 47.19%. AMPH stock has a five-year performance of 93.89%. Its 52-week range is between 17.56 and 44.46, which gives AMPH stock a 52-week price range ratio of 62.16%

Amphastar Pharmaceuticals Inc. currently has a PE ratio of 19.60, a price-to-book (PB) ratio of 3.24, a price-to-sale (PS) ratio of 3.68, a price to cashflow ratio of 12.70, a PEG ratio of 2.32, a ROA of 12.27%, a ROC of 15.49% and a ROE of 18.86%. The company’s profit margin is 18.37%, its EBITDA margin is 29.90%, and its revenue ttm is $455.12 Million , which makes it $9.32 revenue per share.

Of the last four earnings reports from Amphastar Pharmaceuticals Inc., there were 3 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.30 for the next earnings report. Amphastar Pharmaceuticals Inc.’s next earnings report date is 08th Aug 2022.

The consensus rating of Wall Street analysts for Amphastar Pharmaceuticals Inc. is Moderate Buy (2), with a target price of $45, which is +31.27% compared to the current price. The earnings rating for Amphastar Pharmaceuticals Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Amphastar Pharmaceuticals Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Amphastar Pharmaceuticals Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 9.70, ATR14 : 2.05, CCI20 : -46.09, Chaikin Money Flow : -0.07, MACD : -1.14, Money Flow Index : 40.40, ROC : -23.26, RSI : 43.34, STOCH (14,3) : 22.97, STOCH RSI : 0.51, UO : 43.14, Williams %R : -77.03), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Amphastar Pharmaceuticals Inc. in the last 12-months were: Floyd F. Petersen (Option Excercise at a value of $347 179), Floyd F. Petersen (Sold 13 219 shares of value $436 337 ), Howard Lee (Option Excercise at a value of $347 179), Howard Lee (Sold 20 291 shares of value $738 182 ), Jack Yongfeng Zhang (Sold 237 871 shares of value $8 297 123 ), Jacob Liawatidewi (Option Excercise at a value of $545 275), Jacob Liawatidewi (Sold 40 456 shares of value $819 493 ), Michael A. Zasloff (Option Excercise at a value of $347 179), Michael A. Zasloff (Sold 20 291 shares of value $703 569 ), Richard Prins (Option Excercise at a value of $347 179), Richard Prins (Sold 20 291 shares of value $559 314 ), Rong Zhou (Option Excercise at a value of $486 160), Rong Zhou (Sold 61 484 shares of value $1 524 812 ), William J. Peters (Option Excercise at a value of $2 318 597), William J. Peters (Sold 182 836 shares of value $5 178 840 )